Please enter verification code
Home / Journals American Journal of Life Sciences / Pharmacogenomics & Personalized Medicine
Pharmacogenomics & Personalized Medicine
Submission Deadline: Nov. 30, 2014
Lead Guest Editor
Institute of Clinical Pharmacology, Xiangya Hospital, Central south university, Hunan, China
Guest Editors
  • Yan Shu
    Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, USA
  • Shengying Qin
    Biophysiqe Laboratory Department of Nuclear Medicine, Faculty of Medicine, Cadi Ayyad University, Shanghai, China
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
Authors: Shan Cao, Gan Zhou, Yao Chen, Dong Guo, Zhi-rong Tan, Lan Fan, Hai-tang Hu, Xiang-hong Qin, Hong-hao Zhou, Dong-sheng Ouyang, Wei Zhang
Pages: 14-20 Published Online: Jan. 27, 2015
Views 3671 Downloads 156
Authors: Zhiying Luo, Xi Li, Mouze Liu, Yan Shu, Jiye Yin, Xiaoping Chen, Jianquan Luo, Xiaobing Li, Wei Zhang
Pages: 7-13 Published Online: Dec. 27, 2014
Views 3397 Downloads 158
Authors: Zhiying Luo, Fazhong He, Jianquan Luo, Wei Zhang
Pages: 1-6 Published Online: Nov. 24, 2014
Views 3331 Downloads 177
Pharmacogenomics is the study of the role of genetics in drug disposition and response. Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Such approaches promise the advent of "personalized medicine"; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. It’s the future model of life science and health care. Reviews and reports by the researchers are involved in this rapidly developing area. This issue focuses on those aspects:

1. The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies
2. Emerging technologies for accessing and exploiting genomic information
3. Reviews of genotyping and clinical data in particular therapeutic areas
4. Development of novel diagnostic products and strategies
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186